InsidersTradesSigma
동성제약 Stock: price and directors' dealings · South Korea · DART (FSS)
Follow the 동성제약 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 동성제약 has recorded 41 public disclosures. Market capitalisation: €94bn. The latest transaction was filed on 6 April 2026 (Purchase). Among the most active insiders: 이양구. All data is openly available.
41
Insider Decl.
0
Thresholds
€40m
26 ops.
Buy Volume
·
0 ops.
Sell Volume
12Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 23,498 of 26,212 companies
22.4
score / 100
Value11
Quality34
FCF yld-15%
Earn yld-27%
EV/EBITDA·
ROE2.9%
Gross mgn43%
Net mgn-30%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 6 April 2026
Declarations41 total
31,500,000 shares@ ₩1,000.000.017% mcap100.0% of flowShareKRXDART:20260406003057
Ideal exit: 26 Dec 2026 (T+270)
8,500,000 shares@ ₩1,000.000.0046% mcap100.0% of flowShareKRXDART:20260406003088
Ideal exit: 26 Dec 2026 (T+270)
25 of 41 declarations